Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Immunic Inc. buy Wedbush

Start price
€1.84
04.08.23 / 50%
Target price
€4.53
04.08.24
Performance (%)
-35.38%
End price
€1.19
05.08.24
Summary
This prediction ended on 05.08.24 with a price of €1.19. Massive losses of -35.38% were the result for the BUY prediction by Wedbush. Wedbush has a follow-up prediction for Immunic Inc. where he still thinks Immunic Inc. is a Buy. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Immunic Inc. 0.981% 0.981% -20.783%
iShares Core DAX® 2.821% -1.953% 15.071%
iShares Nasdaq 100 5.285% -5.092% 29.254%
iShares Nikkei 225® 3.687% -4.221% 14.286%
iShares S&P 500 3.577% -2.240% 25.546%

Comments by Wedbush for this prediction

In the thread Immunic Inc. diskutieren
Prediction Buy
Perf. (%) -35.38%
Target price 4.531
Change
Ends at 04.08.24

Immunic, Inc. (NASDAQ: IMUX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat

In the thread Trading Immunic Inc.
Prediction Buy
Perf. (%) -35.38%
Target price 4.531
Change
Ends at 04.08.24

Die von Wedbush gewählte maximale Laufzeit wurde überschritten

Current prediction by Wedbush for Immunic Inc.

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.65
10.10.23
€6.61
10.10.24
-25.15%
15.08.24

Stopped prediction by Wedbush for Immunic Inc.

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€0.93
14.11.23
€6.43
14.11.24
33.01%
15.08.24

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€2.08
27.07.23
€4.53
27.07.24
-35.74%
28.07.24